3-(5-anthracen-9-yl-1,7-naphthyridin-8-yl)-2-[4-(3,6-dimethoxycarbazol-9-yl)phenyl]phenanthro[9,10-d]imidazole;3-(5-anthracen-9-yl-2-pyridinyl)-2-[4-(3,6-dimethoxycarbazol-9-yl)phenyl]phenanthro[9,10-d]imidazole;3-(6-anthracen-9-yl-3-pyridinyl)-2-[4-(3,6-dimethoxycarbazol-9-yl)phenyl]phenanthro[9,10-d]imidazole

C165H109N13O6 — CID 160507511

IUPAC3-(5-anthracen-9-yl-1,7-naphthyridin-8-yl)-2-[4-(3,6-dimethoxycarbazol-9-yl)phenyl]phenanthro[9,10-d]imidazole;3-(5-anthracen-9-yl-2-pyridinyl)-2-[4-(3,6-dimethoxycarbazol-9-yl)phenyl]phenanthro[9,10-d]imidazole;3-(6-anthracen-9-yl-3-pyridinyl)-2-[4-(3,6-dimethoxycarbazol-9-yl)phenyl]phenanthro[9,10-d]imidazole
SMILESCOc1ccc2c(c1)c1cc(OC)ccc1n2-c1ccc(-c2nc3c4ccccc4c4ccccc4c3n2-c2ccc(-c3c4ccccc4cc4ccccc34)cn2)cc1.COc1ccc2c(c1)c1cc(OC)ccc1n2-c1ccc(-c2nc3c4ccccc4c4ccccc4c3n2-c2ccc(-c3c4ccccc4cc4ccccc34)nc2)cc1.COc1ccc2c(c1)c1cc(OC)ccc1n2-c1ccc(-c2nc3c4ccccc4c4ccccc4c3n2-c2ncc(-c3c4ccccc4cc4ccccc34)c3cccnc23)cc1
InChIInChI=1S/C57H37N5O2.2C54H36N4O2/c1-63-38-25-27-50-47(31-38)48-32-39(64-2)26-28-51(48)61(50)37-23-21-34(22-24-37)56-60-53-44-18-9-7-16-42(44)43-17-8-10-19-46(43)55(53)62(56)57-54-45(20-11-29-58-54)49(33-59-57)52-40-14-5-3-12-35(40)30-36-13-4-6-15-41(36)52;1-59-38-24-26-48-46(30-38)47-31-39(60-2)25-27-49(47)57(48)37-22-19-33(20-23-37)54-56-52-44-17-9-7-15-42(44)43-16-8-10-18-45(43)53(52)58(54)50-28-21-36(32-55-50)51-40-13-5-3-11-34(40)29-35-12-4-6-14-41(35)51;1-59-38-24-27-49-46(30-38)47-31-39(60-2)25-28-50(47)57(49)36-21-19-33(20-22-36)54-56-52-44-17-9-7-15-42(44)43-16-8-10-18-45(43)53(52)58(54)37-23-26-48(55-32-37)51-40-13-5-3-11-34(40)29-35-12-4-6-14-41(35)51/h3-33H,1-2H3;2*3-32H,1-2H3
InChIKeyQSPJZDAPFQZLNQ-UHFFFAOYSA-N
MW2369.77 g/mol
LogP40.99
Rot. Bonds18

About 3-(5-anthracen-9-yl-1,7-naphthyridin-8-yl)-2-[4-(3,6-dimethoxycarbazol-9-yl)phenyl]phenanthro[9,10-d]imidazole;3-(5-anthracen-9-yl-2-pyridinyl)-2-[4-(3,6-dimethoxycarbazol-9-yl)phenyl]phenanthro[9,10-d]imidazole;3-(6-anthracen-9-yl-3-pyridinyl)-2-[4-(3,6-dimethoxycarbazol-9-yl)phenyl]phenanthro[9,10-d]imidazole

3-(5-anthracen-9-yl-1,7-naphthyridin-8-yl)-2-[4-(3,6-dimethoxycarbazol-9-yl)phenyl]phenanthro[9,10-d]imidazole;3-(5-anthracen-9-yl-2-pyridinyl)-2-[4-(3,6-dimethoxycarbazol-9-yl)phenyl]phenanthro[9,10-d]imidazole;3-(6-anthracen-9-yl-3-pyridinyl)-2-[4-(3,6-dimethoxycarbazol-9-yl)phenyl]phenanthro[9,10-d]imidazole (PubChem CID 160507511) has the molecular formula C165H109N13O6 and a molecular weight of 2369.77 g/mol. Its IUPAC name is 3-(5-anthracen-9-yl-1,7-naphthyridin-8-yl)-2-[4-(3,6-dimethoxycarbazol-9-yl)phenyl]phenanthro[9,10-d]imidazole;3-(5-anthracen-9-yl-2-pyridinyl)-2-[4-(3,6-dimethoxycarbazol-9-yl)phenyl]phenanthro[9,10-d]imidazole;3-(6-anthracen-9-yl-3-pyridinyl)-2-[4-(3,6-dimethoxycarbazol-9-yl)phenyl]phenanthro[9,10-d]imidazole.

Molecular Properties

Compound Name3-(5-anthracen-9-yl-1,7-naphthyridin-8-yl)-2-[4-(3,6-dimethoxycarbazol-9-yl)phenyl]phenanthro[9,10-d]imidazole;3-(5-anthracen-9-yl-2-pyridinyl)-2-[4-(3,6-dimethoxycarbazol-9-yl)phenyl]phenanthro[9,10-d]imidazole;3-(6-anthracen-9-yl-3-pyridinyl)-2-[4-(3,6-dimethoxycarbazol-9-yl)phenyl]phenanthro[9,10-d]imidazole
PubChem CID160507511
Molecular FormulaC165H109N13O6
Molecular Weight2369.77 g/mol
Exact Mass2367.86
IUPAC Name3-(5-anthracen-9-yl-1,7-naphthyridin-8-yl)-2-[4-(3,6-dimethoxycarbazol-9-yl)phenyl]phenanthro[9,10-d]imidazole;3-(5-anthracen-9-yl-2-pyridinyl)-2-[4-(3,6-dimethoxycarbazol-9-yl)phenyl]phenanthro[9,10-d]imidazole;3-(6-anthracen-9-yl-3-pyridinyl)-2-[4-(3,6-dimethoxycarbazol-9-yl)phenyl]phenanthro[9,10-d]imidazole
SMILESCOc1ccc2c(c1)c1cc(OC)ccc1n2-c1ccc(-c2nc3c4ccccc4c4ccccc4c3n2-c2ccc(-c3c4ccccc4cc4ccccc34)cn2)cc1.COc1ccc2c(c1)c1cc(OC)ccc1n2-c1ccc(-c2nc3c4ccccc4c4ccccc4c3n2-c2ccc(-c3c4ccccc4cc4ccccc34)nc2)cc1.COc1ccc2c(c1)c1cc(OC)ccc1n2-c1ccc(-c2nc3c4ccccc4c4ccccc4c3n2-c2ncc(-c3c4ccccc4cc4ccccc34)c3cccnc23)cc1
InChIInChI=1S/C57H37N5O2.2C54H36N4O2/c1-63-38-25-27-50-47(31-38)48-32-39(64-2)26-28-51(48)61(50)37-23-21-34(22-24-37)56-60-53-44-18-9-7-16-42(44)43-17-8-10-19-46(43)55(53)62(56)57-54-45(20-11-29-58-54)49(33-59-57)52-40-14-5-3-12-35(40)30-36-13-4-6-15-41(36)52;1-59-38-24-26-48-46(30-38)47-31-39(60-2)25-27-49(47)57(48)37-22-19-33(20-23-37)54-56-52-44-17-9-7-15-42(44)43-16-8-10-18-45(43)53(52)58(54)50-28-21-36(32-55-50)51-40-13-5-3-11-34(40)29-35-12-4-6-14-41(35)51;1-59-38-24-27-49-46(30-38)47-31-39(60-2)25-28-50(47)57(49)36-21-19-33(20-22-36)54-56-52-44-17-9-7-15-42(44)43-16-8-10-18-45(43)53(52)58(54)37-23-26-48(55-32-37)51-40-13-5-3-11-34(40)29-35-12-4-6-14-41(35)51/h3-33H,1-2H3;2*3-32H,1-2H3
InChIKeyQSPJZDAPFQZLNQ-UHFFFAOYSA-N
XLogP40.99
TPSA175.19 Ų
H-Bond Donors
H-Bond Acceptors19
Rotatable Bonds18
Heavy Atoms184
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002369.77
LogP ≤ 540.99
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1019

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Polycyclic_aromatic_hydrocarbon_2', 'substructure': 'N/A'}, {'alert_name': 'Polycyclic_aromatic_hydrocarbon_3', 'substructure': 'N/A'}

Analyze 3-(5-anthracen-9-yl-1,7-naphthyridin-8-yl)-2-[4-(3,6-dimethoxycarbazol-9-yl)phenyl]phenanthro[9,10-d]imidazole;3-(5-anthracen-9-yl-2-pyridinyl)-2-[4-(3,6-dimethoxycarbazol-9-yl)phenyl]phenanthro[9,10-d]imidazole;3-(6-anthracen-9-yl-3-pyridinyl)-2-[4-(3,6-dimethoxycarbazol-9-yl)phenyl]phenanthro[9,10-d]imidazole with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 3-(5-anthracen-9-yl-1,7-naphthyridin-8-yl)-2-[4-(3,6-dimethoxycarbazol-9-yl)phenyl]phenanthro[9,10-d]imidazole;3-(5-anthracen-9-yl-2-pyridinyl)-2-[4-(3,6-dimethoxycarbazol-9-yl)phenyl]phenanthro[9,10-d]imidazole;3-(6-anthracen-9-yl-3-pyridinyl)-2-[4-(3,6-dimethoxycarbazol-9-yl)phenyl]phenanthro[9,10-d]imidazole?
The IUPAC name of 3-(5-anthracen-9-yl-1,7-naphthyridin-8-yl)-2-[4-(3,6-dimethoxycarbazol-9-yl)phenyl]phenanthro[9,10-d]imidazole;3-(5-anthracen-9-yl-2-pyridinyl)-2-[4-(3,6-dimethoxycarbazol-9-yl)phenyl]phenanthro[9,10-d]imidazole;3-(6-anthracen-9-yl-3-pyridinyl)-2-[4-(3,6-dimethoxycarbazol-9-yl)phenyl]phenanthro[9,10-d]imidazole (CID 160507511) is 3-(5-anthracen-9-yl-1,7-naphthyridin-8-yl)-2-[4-(3,6-dimethoxycarbazol-9-yl)phenyl]phenanthro[9,10-d]imidazole;3-(5-anthracen-9-yl-2-pyridinyl)-2-[4-(3,6-dimethoxycarbazol-9-yl)phenyl]phenanthro[9,10-d]imidazole;3-(6-anthracen-9-yl-3-pyridinyl)-2-[4-(3,6-dimethoxycarbazol-9-yl)phenyl]phenanthro[9,10-d]imidazole.
What is the SMILES notation for 3-(5-anthracen-9-yl-1,7-naphthyridin-8-yl)-2-[4-(3,6-dimethoxycarbazol-9-yl)phenyl]phenanthro[9,10-d]imidazole;3-(5-anthracen-9-yl-2-pyridinyl)-2-[4-(3,6-dimethoxycarbazol-9-yl)phenyl]phenanthro[9,10-d]imidazole;3-(6-anthracen-9-yl-3-pyridinyl)-2-[4-(3,6-dimethoxycarbazol-9-yl)phenyl]phenanthro[9,10-d]imidazole?
The canonical SMILES for 3-(5-anthracen-9-yl-1,7-naphthyridin-8-yl)-2-[4-(3,6-dimethoxycarbazol-9-yl)phenyl]phenanthro[9,10-d]imidazole;3-(5-anthracen-9-yl-2-pyridinyl)-2-[4-(3,6-dimethoxycarbazol-9-yl)phenyl]phenanthro[9,10-d]imidazole;3-(6-anthracen-9-yl-3-pyridinyl)-2-[4-(3,6-dimethoxycarbazol-9-yl)phenyl]phenanthro[9,10-d]imidazole is COc1ccc2c(c1)c1cc(OC)ccc1n2-c1ccc(-c2nc3c4ccccc4c4ccccc4c3n2-c2ccc(-c3c4ccccc4cc4ccccc34)cn2)cc1.COc1ccc2c(c1)c1cc(OC)ccc1n2-c1ccc(-c2nc3c4ccccc4c4ccccc4c3n2-c2ccc(-c3c4ccccc4cc4ccccc34)nc2)cc1.COc1ccc2c(c1)c1cc(OC)ccc1n2-c1ccc(-c2nc3c4ccccc4c4ccccc4c3n2-c2ncc(-c3c4ccccc4cc4ccccc34)c3cccnc23)cc1.
What is the InChIKey of 3-(5-anthracen-9-yl-1,7-naphthyridin-8-yl)-2-[4-(3,6-dimethoxycarbazol-9-yl)phenyl]phenanthro[9,10-d]imidazole;3-(5-anthracen-9-yl-2-pyridinyl)-2-[4-(3,6-dimethoxycarbazol-9-yl)phenyl]phenanthro[9,10-d]imidazole;3-(6-anthracen-9-yl-3-pyridinyl)-2-[4-(3,6-dimethoxycarbazol-9-yl)phenyl]phenanthro[9,10-d]imidazole?
The InChIKey is QSPJZDAPFQZLNQ-UHFFFAOYSA-N. The full InChI is InChI=1S/C57H37N5O2.2C54H36N4O2/c1-63-38-25-27-50-47(31-38)48-32-39(64-2)26-28-51(48)61(50)37-23-21-34(22-24-37)56-60-53-44-18-9-7-16-42(44)43-17-8-10-19-46(43)55(53)62(56)57-54-45(20-11-29-58-54)49(33-59-57)52-40-14-5-3-12-35(40)30-36-13-4-6-15-41(36)52;1-59-38-24-26-48-46(30-38)47-31-39(60-2)25-27-49(47)57(48)37-22-19-33(20-23-37)54-56-52-44-17-9-7-15-42(44)43-16-8-10-18-45(43)53(52)58(54)50-28-21-36(32-55-50)51-40-13-5-3-11-34(40)29-35-12-4-6-14-41(35)51;1-59-38-24-27-49-46(30-38)47-31-39(60-2)25-28-50(47)57(49)36-21-19-33(20-22-36)54-56-52-44-17-9-7-15-42(44)43-16-8-10-18-45(43)53(52)58(54)37-23-26-48(55-32-37)51-40-13-5-3-11-34(40)29-35-12-4-6-14-41(35)51/h3-33H,1-2H3;2*3-32H,1-2H3.
What are the key properties of 3-(5-anthracen-9-yl-1,7-naphthyridin-8-yl)-2-[4-(3,6-dimethoxycarbazol-9-yl)phenyl]phenanthro[9,10-d]imidazole;3-(5-anthracen-9-yl-2-pyridinyl)-2-[4-(3,6-dimethoxycarbazol-9-yl)phenyl]phenanthro[9,10-d]imidazole;3-(6-anthracen-9-yl-3-pyridinyl)-2-[4-(3,6-dimethoxycarbazol-9-yl)phenyl]phenanthro[9,10-d]imidazole?
3-(5-anthracen-9-yl-1,7-naphthyridin-8-yl)-2-[4-(3,6-dimethoxycarbazol-9-yl)phenyl]phenanthro[9,10-d]imidazole;3-(5-anthracen-9-yl-2-pyridinyl)-2-[4-(3,6-dimethoxycarbazol-9-yl)phenyl]phenanthro[9,10-d]imidazole;3-(6-anthracen-9-yl-3-pyridinyl)-2-[4-(3,6-dimethoxycarbazol-9-yl)phenyl]phenanthro[9,10-d]imidazole has a molecular weight of 2369.77 g/mol, XLogP of 40.99, 18 rotatable bonds, 0 hydrogen bond donors, and 19 hydrogen bond acceptors.
Where does this data come from?
All data for 3-(5-anthracen-9-yl-1,7-naphthyridin-8-yl)-2-[4-(3,6-dimethoxycarbazol-9-yl)phenyl]phenanthro[9,10-d]imidazole;3-(5-anthracen-9-yl-2-pyridinyl)-2-[4-(3,6-dimethoxycarbazol-9-yl)phenyl]phenanthro[9,10-d]imidazole;3-(6-anthracen-9-yl-3-pyridinyl)-2-[4-(3,6-dimethoxycarbazol-9-yl)phenyl]phenanthro[9,10-d]imidazole is sourced from PubChem (CID 160507511), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).